Effects of MPP+ on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells

Area of Science:

• Neuroscience
• Cell Biology
• Toxicology

Background:

• 1-methyl-4-phenylpyridinium ion (MPP(+)) is a widely used neurotoxin for modeling Parkinson's disease (PD).
• The precise molecular mechanisms underlying MPP(+)-induced cell death remain incompletely understood.
• Investigating these mechanisms is crucial for developing effective PD therapies.

Purpose of the Study:

• To elucidate the molecular pathways involved in MPP(+)-induced cell death in a neuroblastoma-derived dopaminergic cell line (B65).
• To characterize the effects of MPP(+) on cell cycle regulation and DNA damage response.
• To determine the role of oxidative stress in MPP(+)-mediated cellular toxicity.

Main Methods:

• Exposure of B65 cells to MPP(+) and assessment of cell death.
• Evaluation of caspase and calpain inhibition on MPP(+)-induced toxicity.
• Analysis of p53 activation and cell cycle arrest using flow cytometry.
• Quantification of cell cycle-related proteins (cyclins, cdks, pRb) via Western blotting.
• Assessment of trolox (antioxidant) effects on MPP(+)-induced cell death and cell cycle alterations.

Main Results:

• MPP(+) induced B65 cell death, independent of caspase or calpain pathways.
• MPP(+) treatment activated the p53 DNA damage response and caused G(2)/M cell cycle arrest.
• MPP(+) altered the expression of key cell cycle proteins, increasing cyclins A, E, cdk2, and pRb phosphorylation, while decreasing cyclins D1, B1, and cdk4.
• The antioxidant trolox mitigated MPP(+)-induced cell loss and cell cycle disturbances, indicating oxidative stress involvement.

Conclusions:

• MPP(+)-induced cell death in B65 cells is mediated by oxidative stress, not classical apoptosis or calpain pathways.
• MPP(+) disrupts cell cycle regulation, leading to G(2)/M arrest and altered expression of cell cycle proteins.
• This study provides a detailed molecular characterization of MPP(+)-induced toxicity, highlighting its impact on cell cycle control and implicating oxidative stress in Parkinson's disease models.